Literature DB >> 18362382

The treatment of acute bacterial sinusitis: no change is good medicine.

Nicole Le Saux1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362382      PMCID: PMC2267829          DOI: 10.1503/cmaj.080285

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

Review 1.  Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters.

Authors:  M R Jacobs
Journal:  Clin Microbiol Infect       Date:  2001-11       Impact factor: 8.067

Review 2.  Systematic review of antimicrobial therapy in patients with acute rhinosinusitis.

Authors:  Richard M Rosenfeld; Michael Singer; Stacie Jones
Journal:  Otolaryngol Head Neck Surg       Date:  2007-09       Impact factor: 3.497

Review 3.  Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials.

Authors:  Drosos E Karageorgopoulos; Konstantina P Giannopoulou; Alexandros P Grammatikos; George Dimopoulos; Matthew E Falagas
Journal:  CMAJ       Date:  2008-03-25       Impact factor: 8.262

Review 4.  A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance.

Authors:  Jeffrey D Fuller; Donald E Low
Journal:  Clin Infect Dis       Date:  2005-05-26       Impact factor: 9.079

5.  Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).

Authors:  Lalitagauri M Deshpande; Helio S Sader; Eugenio Debbia; Giuseppe Nicoletti; Giovanni Fadda; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2006-01-19       Impact factor: 2.803

6.  Outpatient treatment of community-acquired pneumonia: evolving trends and a focus on fluoroquinolones.

Authors:  Anita G Carrie; Anita L Kozyrskyj
Journal:  Can J Clin Pharmacol       Date:  2006-03-31

7.  In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002.

Authors:  Jeff Powis; Allison McGeer; Karen Green; Otto Vanderkooi; Karl Weiss; George Zhanel; Tony Mazzulli; Magdalena Kuhn; Deirdre Church; Ross Davidson; Kevin Forward; Daryl Hoban; Andrew Simor; Donald E Low
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

8.  Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine.

Authors:  Mathias W R Pletz; Lesley McGee; James Jorgensen; Bernard Beall; Richard R Facklam; Cynthia G Whitney; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.